Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| HQI | 8-K | bullish | 7/10 | HireQuest reported Q2 2026 results that significantly exceeded consensus estimates, with adjusted EPS of $0.23 beating t | Aug 10, 2026 |
| ACHR | 8-K | mixed | 7/10 | Archer Aviation reported Q2 2026 results with $5.0M revenue (above $1.6M Q1 and $2.0M consensus) and a GAAP net loss of | Aug 10, 2026 |
| SPG | 8-K | bullish | 6/10 | Simon Property Group reported strong Q2 2026 results, with Real Estate FFO per share of $3.29, a 7.9% YoY increase, beat | Aug 10, 2026 |
| INR | 8-K | neutral | 4/10 | Infinity Natural Resources (INR) announced the appointment of Cary Baetz as EVP and CFO, and Andrew Judge as SVP of Fina | Aug 10, 2026 |
| TER | 8-K | neutral | 4/10 | Teradyne entered into a new $1.0 billion senior secured revolving credit facility, replacing its prior credit agreement. | Aug 10, 2026 |
| RKLB | 8-K | bullish | 6/10 | The company guided Q3 2026 revenue to $250M-$265M, above the $230.9M consensus, driven by a record backlog of $2.36B and | Aug 10, 2026 |
| AREN | 8-K | bearish | 7/10 | Arena Group reported Q2 2026 revenue of $22.2M, a 50.7% decline from $45.0M in Q2 2025, and a net loss of $0.2M versus n | Aug 10, 2026 |
| RXT | 8-K | bearish | 6/10 | Rackspace Technology reported Q2 2026 revenue of $670M, up 0.6% YoY, slightly above the $646M consensus estimate. Howeve | Aug 10, 2026 |
| JCTC | 8-K | neutral | 2/10 | Jewett-Cameron Trading Company (JCTC) appointed Scott Kotarba to fill a board vacancy created by Ian Wendler's retiremen | Aug 10, 2026 |
| SANA | 8-K | neutral | 5/10 | Sana Biotechnology reported Q2 2026 GAAP net loss of $63.6M ($0.22/share), a narrower loss vs $93.8M ($0.39/share) in Q2 | Aug 10, 2026 |
| HIMS | 8-K | mixed | 7/10 | Hims & Hers Health reported Q2 2026 revenue of $753.2M (+38% YoY), significantly beating the $730.1M consensus, driven b | Aug 10, 2026 |
| SHIM | 8-K | mixed | 5/10 | Shimmick reported Q2 2026 revenue of $106.6M (down 17% YoY from $128.4M) and a GAAP net loss of $4.8M ($-0.12/share), im | Aug 10, 2026 |
| LIF | 8-K | bullish | 7/10 | Life360 reported a record Q2 2026 with revenue of $159.0M (+38% YoY), beating consensus estimates of $156.7M. EPS of $0. | Aug 10, 2026 |
| GHI | 8-K | bearish | 6/10 | Greystone Housing Impact Investors LP reported Q2 2026 results with a net loss of $1.52M (-$0.11/BUC), a significant det | Aug 10, 2026 |
| ALMR | 8-K | bullish | 7/10 | Alamar Biosciences reported Q2 2026 revenue of $29.4M (+82% YoY), beating the $25.9M consensus, and EPS of -$0.22, beati | Aug 10, 2026 |
| GENK | 8-K | mixed | 7/10 | GEN Restaurant Group reported Q2 2026 revenue of $55.7M (+1.2% YoY), a return to growth after a 6% decline in Q1, driven | Aug 10, 2026 |
| XHLD | 8-K | bearish | 6/10 | TEN Holdings reported Q2 2026 revenue of $731,000, down 34.5% YoY from $1.1M, driven by lower revenue from a large custo | Aug 10, 2026 |
| DH | 8-K | bearish | 6/10 | Definitive Healthcare reported Q2 2026 revenue of $55.2M, a 9% YoY decline from $60.8M, within its guidance range of $55 | Aug 10, 2026 |
| CRWV | 8-K | bullish | 6/10 | CoreWeave closed a $2.6 billion delayed draw term loan facility (DDTL 5.5) through a special-purpose subsidiary, backed | Aug 10, 2026 |
| ALCO | 8-K | bullish | 6/10 | Alico reported Q3 2026 GAAP EPS of $0.29, a 139.7% beat vs consensus of -$0.73, and revenue of $9.04M, beating the $2.8M | Aug 10, 2026 |
| IMDX | 8-K | neutral | 6/10 | IMDX reported Q2 2026 revenue of $239K (GAAP net loss -$0.31/share), essentially pre-revenue as it awaits FDA authorizat | Aug 10, 2026 |
| MGX | 8-K | bearish | 5/10 | Metagenomi reported Q2 2026 results with a net loss of -$0.73 per share, wider than the -$0.63 consensus estimate, and c | Aug 10, 2026 |
| GOOGL | 8-K | neutral | 3/10 | Alphabet completed a $25 billion aggregate principal amount underwritten public offering of U.S. dollar-denominated seni | Aug 10, 2026 |
| HROW | 8-K | mixed | 6/10 | Harrow reported Q2 2026 revenue of $70.7M, an 11% YoY increase and a 60% sequential jump, driven by strong branded produ | Aug 10, 2026 |
| PROK | 8-K | neutral | 5/10 | ProKidney reported Q2 2026 results with no revenue or EPS surprises vs consensus, as the company remains a pre-commercia | Aug 10, 2026 |
| CNNE | 8-K | mixed | 6/10 | Cannae Holdings reported Q2 2026 GAAP net earnings of $37.5M ($0.86 per share), a sharp swing from a $238.8M loss in Q2 | Aug 10, 2026 |
| NHI | 8-K | bearish | 6/10 | NHI reported Q2 2026 Normalized FFO of $1.19 per diluted share, a 2.5% YoY decline and below the $1.26 consensus estimat | Aug 10, 2026 |
| NHI | 8-K | neutral | 3/10 | NHI filed its Q2 2026 supplemental financial information, a routine quarterly disclosure. The filing provides portfolio- | Aug 10, 2026 |
| TELA | 8-K | bearish | 7/10 | TELA Bio reported Q2 2026 revenue of $19.3M, a 4% decline YoY, and an EPS of -$0.20, missing consensus estimates of -$0. | Aug 10, 2026 |
| APEI | 8-K | mixed | 5/10 | APEI reported Q2 2026 revenue of $171.7M (+5.5% YoY) and GAAP diluted EPS of $0.52, a 10.3% miss vs the $0.58 consensus | Aug 10, 2026 |